A clear message from the Kanpur episode is that the cash economy is alive and kicking. Probably, instead of outlawing cash, the Government should try to integrate the cash economy in the formal economy. Also, Direct and Indirect Tax provisions should be harmonised. That said, ersatz solutions like tinkering with tax rates cannot solve the deep-rooted structural problems of our tax system
Leading stem cell bank LifeCell on Thursday said it has received approval from the Drug Controller General of India (DCGI) for a clinical trial of Mesocel.
Truenat is an indigenous portable, battery-operated, Internet of Things-enabled RT-PCR platform developed and manufactured in India. It can test for nearly 30 diseases, and results take less than an hour.
Bharat Biotech’s Covaxin and the Serum Institute of India’s Covishield were recommended by a government-appointed panel to the Drugs Controller General of India (DCGI) for emergency use in the last two days.
The vaccine of two candidates - Bharat Biotech's Covaxin and the Serum Institute of India's Covishield - have been recommended by a government-appointed panel to the DCGI.
